Jan 18, 2016, 10:42 AM by Michael Croft

CAMBRIDGE, UNITED KINGDOM - Jan 18, 2016 - Congenica, a world leading developer of genome analysis technologies, places the highest importance on data security and information governance and is therefore pleased to announce that it has successfully achieved two major milestones: ISO 27001 accreditation and compliance with the NHS Information Governance Toolkit (IGT)

Jan 18, 2016, 10:06 AM by Michael Croft

LONDON, UK - Jan 18, 2016 - Titian (www.titian.co.uk) is launching Mosaic SampleBank™ to offer the benefits of sample management best practice, gained from collaborating with big pharma companies, in a format that is cost-effective and rapid for other institutions to deploy

Jan 18, 2016, 06:01 AM by Michael Croft

CAMBRIDGE, UNITED KINGDOM - Jan 18, 2016 - Morphogen-IX, a new Cambridge-based biotech company, has gained seed funding to develop a new treatment for pulmonary arterial hypertension (PAH) that directly targets the major pathway implicated in human genetic studies

Jan 14, 2016, 14:25 PM by Michael Croft

Bio-IT World News Brief | With funding from the National Human Genome Research Institute, and the National Heart, Lung, and Blood Institute, four new Centers for Common Disease Genomics could receive up to $260 million over four years.

Jan 14, 2016, 10:50 AM by Michael Croft

Bio-IT World News Brief | Intellia Therapeutics, one of three major companies developing drugs based on CRISPR-Cas9 gene editing technology, has announced that its ex vivo programs will now be pursued in a new division of the company called eXtellia Therapeutics.

Jan 13, 2016, 12:51 PM by Michael Croft

ST. LOUIS, MO, UNITED STATES - Jan 13, 2016 - The Donald Danforth Plant Science Center announced it has received a three-year grant from the U.S. Department of Agriculture’s (USDA) National Institute of Food and Agriculture (NIFA) to enhance nitrogen use efficiency (NUE)

Jan 12, 2016, 15:05 PM by Michael Croft

ZDNet | Pathway Genomics last week announced that the app the company has been developing with IBM Watson is now in closed alpha release.

Jan 12, 2016, 14:40 PM by Michael Croft

Bio-IT World | The JP Morgan Healthcare Conference comes but once a year. Now it’s here, now it’s here, and Illumina CEO Jay Flatley has honored his seasonal tradition by releasing a new next-generation sequencer in his address to investors.

Jan 12, 2016, 09:44 AM by Michael Croft

PRINCETON, NJ - Jan 12, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today announced the launch of Certara Strategic Consulting China in Shanghai

Jan 11, 2016, 11:10 AM by Michael Croft

Bio-IT World | Illumina, the dominant manufacturer of DNA sequencing technology, has formed a spinoff company called GRAIL to experiment with a pan-cancer blood test, an undertaking for which hundreds of thousands of patients may be enrolled in clinical studies.

Jan 8, 2016, 14:19 PM by Michael Croft

The Atlantic | A new study revises the most famous "fact" about the microbiome: that microbes outnumber human cells in the body ten to one.

Jan 8, 2016, 13:00 PM by Michael Croft

Bio-IT World | In partnership with Illumina, multinational diagnostics company bioMérieux has launched EpiSeq, the first commercial system to monitor outbreaks in hospitals by sequencing and analyzing the whole genomes of bacteria.

Jan 8, 2016, 10:12 AM by Michael Croft

FierceBiotech | Moderna Therapeutics, a high-profile private biotech with scores of preclinical projects, is finally moving toward human trials, recruiting one of the world's largest CROs to help get its much-hyped pipeline moving.

Jan 6, 2016, 09:38 AM by Michael Croft

Nature News | A new push by the Chinese government for research in genomic health is expected to dwarf the U.S. Precision Medicine Initiative in both scale and funding, although China's shortage of physicians and drug development capacity may make it hard to capitalize on new discoveries.

Jan 5, 2016, 12:15 PM by Michael Croft

Bio-IT World | Still facing a looming patent dispute over its most basic intellectual property, Editas Medicine registered with the SEC for an initial public offering this week, making it the first therapeutics company based on CRISPR-Cas9 gene editing to go public.

Jan 4, 2016, 11:41 AM by Michael Croft

Forbes | The National Institutes of Health expects to shortly phase out its funding for the maintenance of databases like Online Mendelian Inheritance in Man, leaving the future of these invaluable resources for the life sciences uncertain.

Dec 30, 2015, 08:05 AM by Michael Croft

Bio-IT World | The latest products and announcements from around the industry, including the tranSMART Foundation absorbing the OpenBEL project, and an expanded organs-on-chips program at Merck.

Dec 30, 2015, 03:16 AM by Michael Croft

ALBANY, NY, UNITED STATES - Dec 30, 2015 - Substance abuse refers to the use of psychoactive substances, which include alcohol and illicit drugs, to the extent that it is harmful or hazardous

Dec 29, 2015, 13:14 PM by Michael Croft

The Verge | Verge Editors Elizabeth Lopatto and Ben Popper discuss high-tech investors' vulnerability to shaky claims in the life sciences.

Dec 28, 2015, 11:15 AM by Michael Croft

Grist | The tangled history of agricultural technology, and nature's dazzling array of genetic interventions, make it intractably hard to come up with a crisp, consistent meaning for "genetically modified organism."